Shares of Affymax (AFFY) are now up 30% premarket after being halted earlier. All the excitement...


Shares of Affymax (AFFY) are now up 30% premarket after being halted earlier. All the excitement stems from the firm landing FDA backing for its peginesatide anemia drug.

From other sites
Comments (1)
  • hdman
    , contributor
    Comments (28) | Send Message
     
    Its the panel that vote it still has to go to the FDA for aproval !!!
    8 Dec 2011, 09:18 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs